Zurich Insurance Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.34M | Sell |
25,500
-136,249
| -84% | -$11.9M | 0.02% | 256 |
|
|
2026
Q1 | $13.8M | Buy |
161,749
+136,215
| +533% | +$12.1M | 0.11% | 201 |
|
|
2025
Q4 | $2.02M | Hold |
25,534
| – | – | 0.01% | 240 |
|
|
2025
Q3 | $2.04M | Buy |
+25,534
| New | +$2.18M | 0.01% | 201 |
|
|
2024
Q4 | – | Sell |
-574,117
| Closed | -$59.6M | – | 236 |
|
|
2024
Q3 | $59.6M | Buy |
574,117
+554,217
| +2,785% | +$56.5M | 0.51% | 65 |
|
|
2024
Q2 | $1.93M | Hold |
19,900
| – | – | 0.02% | 166 |
|
|
2024
Q1 | $1.79M | Hold |
19,900
| – | – | 0.02% | 187 |
|
|
2023
Q4 | $1.59M | Hold |
19,900
| – | – | 0.02% | 191 |
|
|
2023
Q3 | $1.42M | Hold |
19,900
| – | – | 0.02% | 189 |
|
|
2023
Q2 | $1.53M | Sell |
19,900
-330,403
| -94% | -$25.6M | 0.02% | 170 |
|
|
2023
Q1 | $26.3M | Buy |
350,303
+27,303
| +8% | +$2.03M | 0.33% | 91 |
|
|
2022
Q4 | $25.4M | Buy |
323,000
+303,100
| +1,523% | +$22.7M | 0.36% | 83 |
|
|
2022
Q3 | $1.4M | Hold |
19,900
| – | – | 0.02% | 147 |
|
|
2022
Q2 | $1.59M | Hold |
19,900
| – | – | 0.02% | 152 |
|
|
2022
Q1 | $1.51M | Hold |
19,900
| – | – | 0.02% | 156 |
|
|
2021
Q4 | $1.7M | Hold |
19,900
| – | – | 0.02% | 145 |
|
|
2021
Q3 | $1.5M | Hold |
19,900
| – | – | 0.02% | 159 |
|
|
2021
Q2 | $1.62M | Hold |
19,900
| – | – | 0.02% | 157 |
|
|
2021
Q1 | $1.57M | Buy |
+19,900
| New | +$1.56M | 0.02% | 147 |
|
|
2019
Q4 | – | Sell |
-143,491
| Closed | -$10.5M | – | 274 |
|
|
2019
Q3 | $10.5M | Sell |
143,491
-14,466
| -9% | -$1.05M | 0.2% | 128 |
|
|
2019
Q2 | $11.3M | Buy |
157,957
+14,855
| +10% | +$1.05M | 0.22% | 130 |
|
|
2019
Q1 | $9.81M | Buy |
143,102
+31,328
| +28% | +$2.02M | 0.21% | 145 |
|
|
2018
Q4 | $6.65M | Sell |
111,774
-122,613
| -52% | -$7.67M | 0.16% | 177 |
|
|
2018
Q3 | $15.7M | Buy |
234,387
+61,400
| +35% | +$4.09M | 0.33% | 87 |
|
|
2018
Q2 | $11.2M | Buy |
172,987
+29,569
| +21% | +$1.93M | 0.25% | 109 |
|
|
2018
Q1 | $10.3M | Sell |
143,418
-10,213
| -7% | -$735K | 0.24% | 110 |
|
|
2017
Q4 | $11.6M | Sell |
153,631
-38,401
| -20% | -$2.8M | 0.27% | 86 |
|
|
2017
Q3 | $14M | Sell |
192,032
-5,404
| -3% | -$389K | 0.38% | 58 |
|
|
2017
Q2 | $14.6M | Buy |
197,436
+40,813
| +26% | +$3.03M | 0.41% | 52 |
|
|
2017
Q1 | $11.5M | Buy |
156,623
+11,275
| +8% | +$789K | 0.33% | 64 |
|
|
2016
Q4 | $9.51M | Buy |
145,348
+20,116
| +16% | +$1.38M | 0.3% | 76 |
|
|
2016
Q3 | $9.29M | Sell |
125,232
-26,826
| -18% | -$1.98M | 0.31% | 81 |
|
|
2016
Q2 | $11.1M | Buy |
152,058
+4,428
| +3% | +$315K | 0.39% | 69 |
|
|
2016
Q1 | $10.4M | Sell |
147,630
-4,602
| -3% | -$306K | 0.37% | 68 |
|
|
2015
Q4 | $10.1M | Buy |
152,232
+7,175
| +5% | +$477K | 0.36% | 84 |
|
|
2015
Q3 | $9.21M | Buy |
+145,057
| New | +$9.48M | 0.34% | 102 |
|
Other funds holding CL
Zurich Insurance Group's CL Position: Q2 2026 in Review
Zurich Insurance Group reduced its Colgate-Palmolive (CL) stake by 84% in Q2 2026, selling an estimated $11.9M and leaving 25,500 shares worth $2.34M. The position accounts for 0.02% of the portfolio, ranked #256.
Zurich Insurance Group first reported a position in CL in Q3 2015 and has held it in 36 quarters since. The position peaked at $59.6M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Zurich Insurance Group held 25,500 shares of Colgate-Palmolive worth $2.34M as of Q2 2026.
- Zurich Insurance Group sold 136,249 Colgate-Palmolive shares in Q2 2026, an estimated $11.9M.
- Colgate-Palmolive made up 0.02% of Zurich Insurance Group's portfolio in Q2 2026, its #256 holding.
- Zurich Insurance Group first reported a position in Colgate-Palmolive in Q3 2015 and has held it in 36 quarters since.
- Zurich Insurance Group's Colgate-Palmolive position peaked at $59.6M in Q3 2024.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.